Question 2 Multiple Choice/Single Answer - select only one answer
An adult presents to a physician with attention deficit hyperactivity disorder (ADHD). To date, no behavioral or drug interventions have proven useful. The physician has just read several reports about a drug that is approved and marketed for another indication, but has shown some benefit for ADHD. The physician wants to prescribe this drug, in the labeled marketed dose, for the individual patient. Which of the following would be the most appropriate course of action?
1. Submit an Investigational New Drug (IND) application before treating the subject
2. Treat the patient with the drug based on physician's best medical judgment
3. Inform the patient that the drug cannot be prescribed
4. Submit a research protocol for IRB review and approval before treating the patient
No comments:
Post a Comment